A citation-based method for searching scientific literature

Lena Smirnova, Helena T Hogberg, Marcel Leist, Thomas Hartung. ALTEX 2014
Times Cited: 91







List of co-cited articles
835 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes.
Anna Bal-Price, Kevin M Crofton, Marcel Leist, Sandra Allen, Michael Arand, Timo Buetler, Nathalie Delrue, Rex E FitzGerald, Thomas Hartung, Tuula Heinonen,[...]. Arch Toxicol 2015
97
40

Developmental neurotoxicity of industrial chemicals.
P Grandjean, P J Landrigan. Lancet 2006
38

Neurobehavioural effects of developmental toxicity.
Philippe Grandjean, Philip J Landrigan. Lancet Neurol 2014
863
31

Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.
Michael Aschner, Sandra Ceccatelli, Mardas Daneshian, Ellen Fritsche, Nina Hasiwa, Thomas Hartung, Helena T Hogberg, Marcel Leist, Abby Li, William R Mundi,[...]. ALTEX 2017
77
36

Developmental neurotoxicity testing: a path forward.
Kevin M Crofton, William R Mundy, Timothy J Shafer. Congenit Anom (Kyoto) 2012
71
35

Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants.
Anne K Krug, Nina V Balmer, Florian Matt, Felix Schönenberger, Dorit Merhof, Marcel Leist. Arch Toxicol 2013
96
26

Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation.
Anna K Bal-Price, Sandra Coecke, Lucio Costa, Kevin M Crofton, Ellen Fritsche, Alan Goldberg, Philippe Grandjean, Pamela J Lein, Abby Li, Roberto Lucchini,[...]. ALTEX 2012
75
32

Consensus report on the future of animal-free systemic toxicity testing.
Marcel Leist, Nina Hasiwa, Costanza Rovida, Mardas Daneshian, David Basketter, Ian Kimber, Harvey Clewell, Tilman Gocht, Alan Goldberg, Francois Busquet,[...]. ALTEX 2014
94
25

The dawning of a new age of toxicology.
Marcel Leist, Thomas Hartung, Pierluigi Nicotera. ALTEX 2008
93
24


Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts.
Christoph van Thriel, Remco H S Westerink, Christian Beste, Ambuja S Bale, Pamela J Lein, Marcel Leist. Neurotoxicology 2012
66
31


OECD/EFSA workshop on developmental neurotoxicity (DNT): The use of non-animal test methods for regulatory purposes.
Ellen Fritsche, Kevin M Crofton, Antonio F Hernandez, Susanne Hougaard Bennekou, Marcel Leist, Anna Bal-Price, Elissa Reaves, Martin F Wilks, Andrea Terron, Roland Solecki,[...]. ALTEX 2017
54
37

Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
Anna Bal-Price, Helena T Hogberg, Kevin M Crofton, Mardas Daneshian, Rex E FitzGerald, Ellen Fritsche, Tuula Heinonen, Susanne Hougaard Bennekou, Stefanie Klima, Aldert H Piersma,[...]. ALTEX 2018
76
26

Compound selection for in vitro modeling of developmental neurotoxicity.
Suzanne Kadereit, Bastian Zimmer, Christoph van Thriel, Jan G Hengstler, Marcel Leist. Front Biosci (Landmark Ed) 2012
58
32

Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
Kevin M Crofton, William R Mundy, Pamela J Lein, Anna Bal-Price, Sandra Coecke, Andrea E M Seiler, Holger Knaut, Leonora Buzanska, Alan Goldberg. ALTEX 2011
107
20

Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery.
B Zimmer, G Pallocca, N Dreser, S Foerster, T Waldmann, J Westerhout, S Julien, K H Krause, C van Thriel, J G Hengstler,[...]. Arch Toxicol 2014
55
32

Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells.
Bastian Zimmer, Gabsang Lee, Nina V Balmer, Kesavan Meganathan, Agapios Sachinidis, Lorenz Studer, Marcel Leist. Environ Health Perspect 2012
69
26

Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome.
Nina V Balmer, Matthias K Weng, Bastian Zimmer, Violeta N Ivanova, Stuart M Chambers, Elena Nikolaeva, Smita Jagtap, Agapios Sachinidis, Jürgen Hescheler, Tanja Waldmann,[...]. Hum Mol Genet 2012
70
25

A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426.
Susan L Makris, Kathleen Raffaele, Sandra Allen, Wayne J Bowers, Ulla Hass, Enrico Alleva, Gemma Calamandrei, Larry Sheets, Patric Amcoff, Nathalie Delrue,[...]. Environ Health Perspect 2009
97
18

Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.
Anne K Krug, Raivo Kolde, John A Gaspar, Eugen Rempel, Nina V Balmer, Kesavan Meganathan, Kinga Vojnits, Mathurin Baquié, Tanja Waldmann, Roberto Ensenat-Waser,[...]. Arch Toxicol 2013
160
18

Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
Ellen Fritsche, Philippe Grandjean, Kevin M Crofton, Michael Aschner, Alan Goldberg, Tuula Heinonen, Ellen V S Hessel, Helena T Hogberg, Susanne Hougaard Bennekou, Pamela J Lein,[...]. Toxicol Appl Pharmacol 2018
72
23

Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing.
Philipp B Kuegler, Bastian Zimmer, Tanja Waldmann, Birte Baudis, Sten Ilmjärv, Jürgen Hescheler, Phil Gaughwin, Patrik Brundin, William Mundy, Anna K Bal-Price,[...]. ALTEX 2010
82
19

Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro.
Joshua A Harrill, Brian L Robinette, William R Mundy. Toxicol In Vitro 2011
74
21

In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.
Béla Z Schmidt, Martin Lehmann, Simon Gutbier, Erastus Nembo, Sabrina Noel, Lena Smirnova, Anna Forsby, Jürgen Hescheler, Hasan X Avci, Thomas Hartung,[...]. Arch Toxicol 2017
81
19

A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity.
David Pamies, Paula Barreras, Katharina Block, Georgia Makri, Anupama Kumar, Daphne Wiersma, Lenna Smirnova, Ce Zang, Joseph Bressler, Kimberly M Christian,[...]. ALTEX 2017
102
17

Putative adverse outcome pathways relevant to neurotoxicity.
Anna Bal-Price, Kevin M Crofton, Magdalini Sachana, Timothy J Shafer, Mamta Behl, Anna Forsby, Alan Hargreaves, Brigitte Landesmann, Pamela J Lein, Jochem Louisse,[...]. Crit Rev Toxicol 2015
69
21

State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.
Natalie Alépée, Anthony Bahinski, Mardas Daneshian, Bart De Wever, Ellen Fritsche, Alan Goldberg, Jan Hansmann, Thomas Hartung, John Haycock, Helena Hogberg,[...]. ALTEX 2014
105
16

Expanding the test set: Chemicals with potential to disrupt mammalian brain development.
William R Mundy, Stephanie Padilla, Joseph M Breier, Kevin M Crofton, Mary E Gilbert, David W Herr, Karl F Jensen, Nicholas M Radio, Kathleen C Raffaele, Kelly Schumacher,[...]. Neurotoxicol Teratol 2015
50
30


From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects.
Nina V Balmer, Stefanie Klima, Eugen Rempel, Violeta N Ivanova, Raivo Kolde, Matthias K Weng, Kesavan Meganathan, Margit Henry, Agapios Sachinidis, Michael R Berthold,[...]. Arch Toxicol 2014
60
23


Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+).
A K Krug, S Gutbier, L Zhao, D Pöltl, C Kullmann, V Ivanova, S Förster, S Jagtap, J Meiser, G Leparc,[...]. Cell Death Dis 2014
69
18

Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
Anna Bal-Price, Francesca Pistollato, Magdalini Sachana, Stephanie K Bopp, Sharon Munn, Andrew Worth. Toxicol Appl Pharmacol 2018
64
20

Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells.
Tanja Waldmann, Eugen Rempel, Nina V Balmer, André König, Raivo Kolde, John Antonydas Gaspar, Margit Henry, Jürgen Hescheler, Agapios Sachinidis, Jörg Rahnenführer,[...]. Chem Res Toxicol 2014
79
15


A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.
David A Basketter, Harvey Clewell, Ian Kimber, Annamaria Rossi, Bas Blaauboer, Robert Burrier, Mardas Daneshian, Chantra Eskes, Alan Goldberg, Nina Hasiwa,[...]. ALTEX 2012
139
13

Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived hN2 cells using automated high-content image analysis.
Joshua A Harrill, Theresa M Freudenrich, Dave W Machacek, Steven L Stice, William R Mundy. Neurotoxicology 2010
74
16

Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing.
B Zimmer, P B Kuegler, B Baudis, A Genewsky, V Tanavde, W Koh, B Tan, T Waldmann, S Kadereit, M Leist. Cell Death Differ 2011
75
16

Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity.
Kristen R Ryan, Oksana Sirenko, Fred Parham, Jui-Hua Hsieh, Evan F Cromwell, Raymond R Tice, Mamta Behl. Neurotoxicology 2016
78
15

Cerebral organoids model human brain development and microcephaly.
Madeline A Lancaster, Magdalena Renner, Carol-Anne Martin, Daniel Wenzel, Louise S Bicknell, Matthew E Hurles, Tessa Homfray, Josef M Penninger, Andrew P Jackson, Juergen A Knoblich. Nature 2013
13

Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events.
Jenny Baumann, Kathrin Gassmann, Stefan Masjosthusmann, Denise DeBoer, Farina Bendt, Susanne Giersiefer, Ellen Fritsche. Arch Toxicol 2016
48
25

Integrated testing strategies for safety assessments.
Thomas Hartung, Tom Luechtefeld, Alexandra Maertens, Andre Kleensang. ALTEX 2013
96
12

Mechanistic validation.
Thomas Hartung, Sebastian Hoffmann, Martin Stephens. ALTEX 2013
49
22

Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies.
Sandra Coecke, Alan M Goldberg, Sandra Allen, Leonora Buzanska, Gemma Calamandrei, Kevin Crofton, Lars Hareng, Thomas Hartung, Holger Knaut, Paul Honegger,[...]. Environ Health Perspect 2007
118
12


A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors.
Eugen Rempel, Lisa Hoelting, Tanja Waldmann, Nina V Balmer, Stefan Schildknecht, Marianna Grinberg, John Antony Das Gaspar, Vaibhav Shinde, Regina Stöber, Rosemarie Marchan,[...]. Arch Toxicol 2015
64
17

Metabolomics in toxicology and preclinical research.
Tzutzuy Ramirez, Mardas Daneshian, Hennicke Kamp, Frederic Y Bois, Malcolm R Clench, Muireann Coen, Beth Donley, Steven M Fischer, Drew R Ekman, Eric Fabian,[...]. ALTEX 2013
121
10


miRNA expression profiling in a human stem cell-based model as a tool for developmental neurotoxicity testing.
Giorgia Pallocca, Marco Fabbri, Maria Grazia Sacco, Laura Gribaldo, David Pamies, Incoronata Laurenza, Anna Bal-Price. Cell Biol Toxicol 2013
45
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.